1 | BBIO | BridgeBio Pharma, Inc. | 6.77% |
2 | SLNO | Soleno Therapeutics, Inc. | 6.00% |
3 | RDNT | RadNet, Inc. | 5.95% |
4 | LIVN | LivaNova PLC | 5.69% |
5 | TVTX | Travere Therapeutics, Inc. | 5.55% |
6 | TMDX | TransMedics Group, Inc. | 5.43% |
7 | KALV | KalVista Pharmaceuticals, Inc. | 5.11% |
8 | COLL | Collegium Pharmaceutical, Inc. | 4.44% |
9 | INSM | Insmed Incorporated | 4.37% |
10 | MMSI | Merit Medical Systems, Inc. | 4.17% |
11 | ETNB | 89bio, Inc. | 4.11% |
12 | MDGL | Madrigal Pharmaceuticals, Inc. | 3.71% |
13 | WVE | Wave Life Sciences Ltd. | 3.38% |
14 | GH | Guardant Health, Inc. | 3.32% |
15 | ATEC | Alphatec Holdings, Inc. | 3.28% |
16 | RARE | Ultragenyx Pharmaceutical Inc. | 2.86% |
17 | CORT | Corcept Therapeutics Incorporated | 2.84% |
18 | MIRM | Mirum Pharmaceuticals, Inc. | 2.67% |
19 | COGT | Cogent Biosciences, Inc. | 2.53% |
20 | ITGR | Integer Holdings Corporation | 2.23% |
21 | AXSM | Axsome Therapeutics, Inc. | 2.11% |
22 | ACAD | ACADIA Pharmaceuticals Inc. | 1.94% |
23 | AKRO | Akero Therapeutics, Inc. | 1.71% |
24 | SYRE | Spyre Therapeutics, Inc. | 1.51% |
25 | GMED | Globus Medical, Inc. | 1.37% |
View LFSC holdings |